Previous studies using BLT1KO mice or BLT1 antagonists revealed that BLT1 blockade dramatically inhibits neutrophil infiltration in several inflammatory diseases, such as rheumatoid arthritis, peritonitis and psoriasis, resulting in amelioration of the disease condition [6,10,11,30]. The gene discussed is LTB4R; the disease is psoriasis.